Augmentation of multiple protein kinase activities associated with secondary imatinib resistance in gastrointestinal stromal tumors as revealed by quantitative phosphoproteome analysis
- 1 February 2015
- journal article
- Published by Elsevier in Journal of Proteomics
- Vol. 115, 132-142
Abstract
No abstract availableKeywords
Funding Information
- Special Coordination Fund for Promoting Science and Technology (11800122)
This publication has 38 references indexed in Scilit:
- Gastrointestinal stromal tumourThe Lancet, 2013
- Gastrointestinal stromal tumourThe Lancet, 2007
- PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to ImatinibJournal of Clinical Oncology, 2005
- Biology of Gastrointestinal Stromal TumorsJournal of Clinical Oncology, 2004
- Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)Oncogene, 2004
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998